postmenopausal women

patients requiring hormonal treatment

who performance status 0-2

patients initially included in metaca (au882) protocol

affiliation to a social security scheme (or be the beneficiary of such a plan)

patients who signed the informed consent form

patients witg relapse, with metastases or other cancer

concurrent treatment with a drug test, or participation in a clinical trial within < 30 days

patients carrying an electronic medical device (eg pacemaker)

patients who refused to sign the consent form